Biologic treatment in patients with TB while on anti-TNF treatment

Can biologic treatment be restarted in a patient who developed tuberculosis (TB) while on anti–tumor necrosis factor (TNF) treatment? Can we use anti-TNF agents again in such patients?

Gülen Hatemi, MD: In our experience that is possible. We had only 1 patient who had a recurrence of TB after anti-TNFs were started.

Another concern is being infected with TB again. In patients who have a past history of TB there is always a risk of TB, because people around them may have TB. These patients should be carefully followed-up.

See also

Management of latent TB before biologic treatment How should we manage a patient with latent tuberculosis (TB) infection before starting biologic treatment?
Opioids and osteoporosis Is osteoporosis caused by long-term use of strong opioids a significant clinical problem?
TB risk during biologic treatment with agents other than TNF-alpha inhibitors What is the risk of tuberculosis (TB) during biologic treatment with agents other than tumor necrosis factor (TNF)–alpha inhibitors?
Initial management in rheumatologic emergencies What should be the initial management in rheumatologic emergencies? Which patients should be transported to the ICU?
Extra-articular manifestations in spondyloarthritis A lecture by Dr Filip Van den Bosch, from Ghent University, Belgium, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Giant cell arteritis and other large vessel vasculitis A lecture by Dr Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Selecting drugs in acute gout What should guide our decisions when selecting drugs used in the treatment of acute gout?
NNT, NNF, fragility index, CI: how to understand these numbers A lecture by Dr P.J. Devereaux delivered at Evidence-Based Medicine and Clinical Practice Guidelines in Contemporary Practice in Kraków in May 2017.
2014 International Criteria for Behçet Disease What is new in the 2014 International Criteria for Behçet Disease?
Suspected secondary amyloidosis Secondary amyloidosis is a potentially fatal complication of chronic inflammatory diseases. When should it be suspected?

Biologic treatment in patients with TB while on anti-TNF treatment

Social Media